Aphria Inc. (NASDAQ:APHA) does about 6.14M shares in volume on a normal day but saw 4516881 shares change hands in Monday trading. The company now has a market cap of 1.30B USD and an enterprise value of about $1.25B. Its current market price is $4.87, marking an increase of 3.84% compared to the previous close of $4.69. The 52 week high reached by this stock is $7.14 whilst the lowest price level in 52 weeks is $1.95. The script in recent trading has seen the stock touch a high of $4.90 and a low of $4.632.
Aphria Inc. (APHA) has a 20-day trading average at $4.62 and the current price is -31.79% off the 52-week high compared with 149.74% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.68 and its 200-day simple moving average is $4.23. If we look at the stock’s price movements over the week, volatility stands at 3.85%, which increases to 3.87% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 58.05 to suggest the stock is neutral.
12 analysts observing the Aphria Inc. (APHA) stock have set the 12-month price targets for the company’s shares at between $5.24 and $9.36. The median price target is 21.2% away from the current levels at $6.18.
FactSet Research has provided data showing that 12 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 11 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 17, 2020 when CIBC upgraded the stock to “Sector Outperform” and issued a price target of . Stifel also upgraded the stock to “Buy” from Hold on July 13, 2020 at a price target of .
The current price level is 5.45%, 4.18%, and 15.13% away from its SMA20, SMA50, and SMA200 respectively, with the APHA price moving above the 50-day SMA on August 31. Aphria Inc. (APHA) stock is up 7.03% over the week and 1.99% over the past month. Its price is -6.70% year-to-date and -22.20% over the past year.
Its 12-month price target is $6.18. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $5.24, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $9.36.
Outstanding shares total 267.59M with insiders holding 2.84% of the shares and institutional holders owning 14.42% of the company’s common stock. The price to earnings ratio (P/E ratio) amounts to 16.29. Price to book ratio is 0.91.
According to a U.S. Securities and Exchange Commission filing, ETFMG Alternative Harvest ETF has added its position in Aphria Inc. (APHA) to 6,577,152 shares, mirroring a recent increase by 0.23%. ETFMG Alternative Harvest ETF added 14804.0 shares of Aphria Inc. common stock bringing its total worth to about $31.41 million at the end of recent close, SEC documents show. ETFMG Alternative Harvest ETF isn’t the only investment manager who changed stakes and is followed by Horizons Medical Marijuana Life S, which sold off 0.0 shares to end up with 6,274,017 shares worth $29.96 million. Vanguard Total International Stoc cut their holdings by -0.71% in the company over the course of the most recent quarter. It now holds a 1.32% position in Aphria Inc. thanks to 3.8 million shares amounting to $18.15 million.